Over 34 000 patients are waiting to undergo surgery in various Gauteng public hospitals. A man from Gauteng, who is suffering ...

Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant ...

Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...

CHICAGO -- Adjuvant cemiplimab (Libtayo) significantly improved disease-free survival (DFS) compared with placebo in patients ...

Additional data presented at ASCO highlights Libtayo’s ability to hold off recurrence of a type of skin cancer.